Citation data

CrossRef

Works that cite this article, indexed by Crossref.

11 resultsUpdated October 25, 2026
1

MicroRNA-26a–interleukin (IL)-6–IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model

Clinical and Experimental Immunology 187(1) (2016)

Q He; F Li; J Li; R Li; G Zhan; G Li; W Du; H Tan

2

Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease

Metabolites 14(3) (2024)

Saira Rafaqat; Sanja Gluscevic; Filiz Mercantepe; Sana Rafaqat; Aleksandra Klisic

5

Integrated bioinformatics analysis reveals potential mechanisms associated with intestinal flora intervention in nonalcoholic fatty liver disease

Medicine 101(36) (2022)

Yingying Liu; Xinkui Liu; Wei Zhou; Jingyuan Zhang; Jiarui Wu; Siyu Guo; Shanshan Jia; Haojia Wang; Jialin Li; Yingying Tan

7

Hepatoprotective Effect of Antrodia cinnamomea Mycelium in Patients with Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial

Journal of the American College of Nutrition 40(4) (2021)

Ya-Ling Chiou; Charng-Cherng Chyau; Tsung-Ju Li; Chia-Feng Kuo; Yu-Yling Kang; Chin-Chu Chen; Wang-Sheng Ko

8

Gut microbiota, fatty liver disease, and hepatocellular carcinoma

Liver Research 2(1) (2018)

Huikuan Chu; Brandon Williams; Bernd Schnabl

10

Cytokines Genotype‐Phenotype Correlation in Nonalcoholic Steatohepatitis

Oxidative Medicine and Cellular Longevity 2017(1) (2017)

Ioana Corina Bocsan; Mircea Vasile Milaciu; Raluca Maria Pop; Stefan Cristian Vesa; Lorena Ciumarnean; Daniela Maria Matei; Anca Dana Buzoianu; Giuseppe Valacchi

11

Celastrus orbiculatus Thunb. extracts and celastrol alleviate NAFLD by preserving mitochondrial function through activating the FGF21/AMPK/PGC-1α pathway

Frontiers in Pharmacology 15 (2024)

Junli Xue; Yunchao Liu; Boyan Liu; Xiubin Jia; Xinsheng Fang; Shucun Qin; Ying Zhang